Looking back, most of us will remember 2009 for the incredible swing in fortune it offered to the biotech industry, from widespread survival concerns in the first quarter to some record-making deals in the fourth. But some of last year's developments point to how the industry may evolve in the coming decade. Here, in no particular order, are some of 2009's trends and stories that are shaping our future: